-Context -The standard doses of 13 C-urea in 13 C-urea breath test is 75 mg. Objective -To assess the diagnostic accuracy of 13 C-urea breath test containing 25 mg of 13 C-urea comparing with the standard doses of 75 mg in the diagnosis of Helicobacter pylori infection. Methods -Two hundred seventy adult patients (96 males, 174 females, median age 41 years) performed the standard 13 C-urea breath test (75 mg 13 C-urea) and repeated the 13 C-urea breath test using only 25 mg of 13 C-urea within a 2 week interval. The test was performed using an infrared isotope analyzer. Patients were considered positive if delta over baseline was >4.0‰ at the gold standard test. Results -One hundred sixty-one (59.6%) patients were H. pylori negative and 109 (40.4%) were positive by the gold standard test. Using receiver operating characteristic analysis we established a cut-off value of 3.4% as the best value of 25 mg 13 C-urea breath test to discriminate positive and negative patients, considering the H. pylori prevalence (95% CI: 23.9-37.3) at our setting. Therefore, we obtained to 25 mg 13 C-urea breath test a diagnostic accuracy of 92.9% (95% CI: 88.1-97.9), sensitivity 83.5% (95% CI: 75.4-89.3), specificity 99.4% (95% CI: 96.6-99.9), positive predictive value 98.3% (95% CI: 92.4-99.4), and negative predictive value 93.0% (95% CI: 88.6-96.1). Conclusions -Low-dose 13 C-urea breath test (25 mg 13 C-urea) does not reach accuracy sufficient to be recommended in clinical setting where a 30% prevalence of H. pylori infection is observed. Further studies should be done to determine the diagnostic accuracy of low doses of 13 C-urea in the urea breath test. HEADINGS -Helicobacter infections. Breath tests.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.